| Accession Number: | 0001437749-23-025480 |
| Date: | 2023-09-07 |
| Issuer: | UROGEN PHARMA LTD. (URGN) |
| Original Submission Date: |
WEN LEANA
400 ALEXANDER PARK DRIVE
PRINCETON, NJ 08540
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STOCK OPTION (RIGHT OT BUY) | 16.85 | 2023-09-07 | deemed execution date | A | 10,000 (a) | 2033-09-07 | ordinary shares 10,000 | $16.85 | 10,000 | direct |
| ID | footnote |
|---|---|
| f1 | the shares underlying the stock option will vest in equal quarterly installments over a period of one year. |
